References
- G. Appelboom, et al. Smart wearable body sensors for patient self-assessment and monitoring. Arch Public Health. 2014 Aug.;72:01–09. cited June. 13, 2016. Available. from http://archpublichealth.biomedcentral.com/articles/10.1186/2049-3258-72-28
- Taylor L. “Pharma business model must change radically: KPMG.” Daily News (April 08, 2014), sec. A.p.1
- Ringel M, Tollman P, Hersch G, et al. “Does size matter in R&D productivity. If not, what does?”. Nat Rev Drug Discov. 2013 Oct.;12:901–902. cited Feb 02, 2016. Available from http://www.nature.com/nrd/journal/v12/n12/full/nrd4164.html
- Robinson R. Speciality drugs: an evolving commercial model. Pharma Voice. 2014 Feb.;15:20–23. cited Feb. 13, 2016. Available from http://www.pharmavoice.com/product/2862/
- Internal Author. “3D-Drucker produziert Leicht-Gips aus Bienenwaben.” Deutsche Wirtschafts Nachrichten (Oct. 27, 2014), sec. A.p.1[8] Internal Author. Medikamententest in Frankreich: ein hirntoter, vier menschen in lebensgefahr. Spiegel. 2016 Jan 15; sec. A.pp.1-2.
- Dearden L. France clinical trial: one person brain-dead and five in hospital after drug testing “accident.” in Rennes. Independent. 2016 Jan 15:sec.A.p.1.
- Bloomberg J. “Digital transformation moves pharma ‘beyond the pill’.” Forbes (Aug. 15, 2014), sec.A.p.1
- Mettler L. “Fitnessdaten an einem ort sammeln: apples health-app läuft nun.” Netzwoche (Oct. 01, 2014), sec.A.p.1
- Swan M. Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracing. Int J Environ Res Public Health. 2009 June 13;6:492–525. Available from http://www.mdpi.com/1660-4601/6/2/492
- Healthline. “The best weight loss apps for 2016.” Available from: http://www.healthline.com/health/diet-and-weight-loss/top-iphone-android-apps#3, May 24, 2016 [cited Sep. 02, 2016]
- Healthline. “The best heart disease iphone and android Apps of the year.” Available from: http://www.healthline.com/health/heart-disease/top-iphone-android-apps#2, Aug. 07, 2015 [cited Sep 02, 2016]
- LiveScience. “A good night’s rest: the best sleep apps.” Available from: http://www.livescience.com/49552-best-sleep-apps.html, Jan. 23, 2015 [cited Sep. 02, 2016]
- C. Paton et al.“Self-tracking: social media and personal health records for patient empowerment self-care. Contribution of the IMIA social media working group.” Yerb Med Inform [On- line]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22890336 [June 13, 2016]
- Epocrates. “The #1 medical reference app.” Available from: http://www.epocrates.com, Jan. 31, 2016 [cited Sep. 02, 2016]
- BP. Kovatchev et al. “Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.” Diabetes Care [On- line]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23801798 [June 13, 2016]
- Doximity. Available from: https://www.doximity.com/[Sep. 1, 2016]
- RC. Wagenaar, et al. Continuous monitoring of functional activities using wearable, wireless gyroscope and accelerometer technology Annu Int Conf IEE Med Biol 2011. 2016 June 13. Available from https://www.semanticscholar.org/paper/Continuous-Monitoring-of-Functional-Activities-Wagenaar-Sapir/1ec2d2fe25430abe52cf9a01e488a460dd12817c/pdf
- PWC. “Drug pricing” Available from: http://www.pwc.com/us/en/health-industries/top-health-industry-issues/drug-pricing.html, Jan 31, 2016 [cited Sep. 01, 2016]
- Ocano S (2015, May). “TOP 10: medical apps for doctors and physicians.” Healthcare Global (cited May 18, 2015), sec.A.p.1
- Marwaha S, Savas S. “Navigating a changing health-care environment.” Available from: http://www.google.ch/url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&uact=8&ved=0ahUKEwjKnOmSh6LLAhWrCJoKHY1qBWoQFgg2MAM&url=http%3A%2F%2Fwww.mckinsey.com%2F~%2Fmedia%2Fmckinsey%2Fdotcom%2Fclient_service%2FBTO%2FPDF%2FMOBT26_Pfizer_QA.ashx&usg=AFQjCNHYV1m46X2EUg8ytrugF4lY3zP1OQ, Jan. 25, 2012 [cited Feb. 29, 2016].
- OECD Competition Committee. “Competition and regulation issues in the pharmaceutical industry.” Available from: http://www.oecd.org/competition/sectors/1920540.pdf, Feb. 06, 2001 [cited Mar. 09, 2016].
- PWC. “New regulations bring new risks to life sciences firms.” Available from: http://www.pwc.com/us/en/health-industries/pharma-life-sciences/regulatory-risk-compliance.html, Dec. 15, 2015 [cited Mar. 05, 2016].
- Booz & Company. “Pharma emerging markets 2.2. how emerging markets are driving the transformation of the pharmaceutical industry.” Available from: http://www.strategyand.pwc.com/media/file/Strategyand_Pharma-Emerging-Markets-2.0.pdf, Dec.31, 2015 [cited Sep. 01, 2016].
- G. Reh et al. “2015 global life sciences outlook. Adapting in an era of transformation.” Available from: https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2015-life-sciences-report.pdf, Dec. 12, 2014 [cited Mar 01, 2016].
- William N. “European council approves first-ever analysis of drug prices with look at IP rights”. Intellectual Property Watch (June 17, 2016), sec.A.p.1
- Evans P. “G7 ultimatum to drug makers on antibiotics.” The Sunday Time (Feb. 07, 2016), sec. A.p.1
- European Medicine Agency. “Good pharmacovigilance practices” Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp Aug. 15, 2016 [cited Sep. 01, 2016].
- IBIS World. “Global biotechnology: market research report.” Available from: http://www.ibisworld.com/industry/global/global-biotechnology.html, Jan. 10, 2016 [cited Mar 01, 2016].
- Baxter. “Improving access to renal therapy in China.” Available from: http://www.baxter.com/corporate-responsibility/sustainability/resources/case-studies/2012-china-renal-therapy.page, Dec 01, 2012 [cited Sep. 02, 2016].
- European Union. “Innovative partnership ensures cheaper insulin in Africa.” Available from: https://europa.eu/eyd2015/en/novo-nordisk/stories/innovative-partnership-ensures-cheaper-insulin-africa, Oct 29, 2015 [cited Sep. 02, 2016].
- PWC. “New entrants: charting the health industry’s risk and regulatory landscape. Where risk meets opportunity.” Available from: http://www.pwc.com/us/en/health-industries/our-perspective/assets/pwc-healthcare-new-entrants-whitepaper.pdf, July 31, 2015 [cited Mar. 01, 2016].
- Mullin R. “Cost to develop new pharmaceutical drug now exceeds $2.5B.” Scientific American (Nov. 24, 2014), sec. A. p.1
- Tufts. “Tufts CSDD assessment of cost to develop and win marketing approval for a new drug now published.” Available from: http://csdd.tufts.edu/news/complete_story/tufts_csdd_rd_cost_study_now_published, Mar 10, 2016 [cited Sep. 01, 2016].
- Clorkson C. “Studies fuel criticism of high drug development cost.” Financial Times (Feb. 15, 2016), sec. A. pp.1-2
- Humer C. “Exclusive: makers took big price increases on widely used U.S. drugs.“ Thomas Retuern (Apr. 05, 2016), sec.A.pp.1
- Merrill M. “The high cost of inventing new drugs - and of not inventing them.” Forbes (Apr. 11, 2015), sec. A. pp. 1-3
- Assembly and the Workig Groups. “International medical products anti-counterfeiting taskforce.” Available from: http://apps.who.int/impact/handbook_impact.pdf?ua=1, 2006-2010 [cited Sep. 01, 2016].
- Edwards M. “R&D in emerging markets: a new approach for a new Era.” Available from: http://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/r-and-38d-in-emerging-markets-a-new-approach-for-a-new-era, Feb. 12, 2010 [cited Mar. 01, 2016].
- Somra G. “Deadly fake viagra: online pharmacies suspected of selling counterfeit drugs.” CNN (Aug. 31, 2015), sec. A. p.1
- Internal Author. “Pfizer, lily and other giants team up to fight counterfeits.” Available from: http://www.in-pharmatechnologist.com/Regulatory-Safety/Pfizer-Lilly-and-other-giants-team-up-to-fight-counterfeits Nov. 23, 2015 [cited Mar. 05, 2016].
- The World Bank. “Anemic recovery in emerging markets to weigh heavily on global growth in 2016.” Available from: http://www.worldbank.org/en/news/press-release/2016/01/06/anemic-recovery-in-emerging-markets-to-weigh-heavily-on-global-growth-in-2016, Jan. 06, 2016 [cited Mar 07, 2016].
- World Economic Forum. “Health systems leapfrogging in emerging economies project paper 5.” Available from: http://www3.weforum.org/docs/WEF_HealthSystem_LeapfroggingEmergingEconomies_ProjectPaper_2014.pdf, Nov. 12, 2014 [cited Feb. 11, 2016].
- Lee H. “China’s drug price-cuts are hitting big pharma where it hurts.” Bloomberg News (Mar. 08, 2016), sex. A.p.1
- Miller J. “Novartis hit by China, emerging market slowdown - CEO on CNBC.” Reuters (Sep. 18, 2015), sec. A.p.1
- McKeown RE. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med.2009 July 1;3:19S-26S. cited Apr. 27, 2016. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805833
- United Nations, Department of Economic and Social Affairs, Population Division. “World population ageing 2015.” Available from: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2015_InfoChart.pdf, Dec. 28, 2015 [cited Feb. 11, 2016].
- United Nations. “World Population Ageing 1950-2050.” Available from: http://www.un.org/esa/population/publications/worldageing19502050/pdf/80chapterii.pdf, Feb. 12, 2010 [cited Feb. 23, 2016].
- OECD Insights. “Health systems are still not prepared for an ageing population.” Available from: http://oecdinsights.org/2015/04/29/health-systems-are-still-not-prepared-for-an-ageing-population/, Apr. 29, 2015 [cited Feb. 14, 2016].
- World Health Organization. “Health transition”. Available from: http://www.who.int/trade/glossary/story050/en/, Feb. 13, 2007 [cited Apr. 26, 2016].
- B. Rechel et al. “How can health systems respond to population ageing?” Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/64966/E92560.pdf, June 15, 2009 [cited Feb. 14, 2016].
- Health Insurance Group. “Speciality drug.” Available from: https://www.healthinsurance.org/glossary/specialty-drug, Dec. 31, 2015 [cited Feb. 29, 2016].
- The Jackson Laboratory. “What is personalized medicine?” Available from: https://www.jax.org/genetics-and-healthcare/personalized-medicine/what-is-personalized-medicine, Dec. 31, 2015 [cited Feb. 29, 2016].
- A.Ward et al. “Three pharma deals worth $45bn reignite M&A boom.” Available from: http://www.ft.com/cms/s/0/a0199164-0d38-11e6-b41f-0beb7e589515.html, Apr. 28, 2016 [cited July 28, 2016].